TP53 and cancer: From further mechanistic studies, BET inhibition has been shown to suppress cancer through inhibition of Myc expression, targeting JAK-STAT, NF-κB pathway, and p53 acetylation (Chan et al. 2015; Huang et al. 2017; Xu and Vakoc 2017).